Global Cardiopulmonary Assisted Membrane Oxygenator Market Growth 2026-2032

June 2026 | 97 pages | ID: G0FD8B672B7BEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Cardiopulmonary Assisted Membrane Oxygenator market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Extracorporeal Membrane Oxygenation (ECMO) is an extracorporeal life support device used to support and replace patients with severe heart or lung failure. ECMO helps maintain normal oxygen levels and carbon dioxide removal in the body by draining the patient's blood from the body to a device outside the body where gas exchange (oxygenation and carbon dioxide removal) occurs and then returning the blood to the body.

United States market for Cardiopulmonary Assisted Membrane Oxygenator is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Cardiopulmonary Assisted Membrane Oxygenator is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Cardiopulmonary Assisted Membrane Oxygenator is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Cardiopulmonary Assisted Membrane Oxygenator players cover GETINGE, PROCIRCA, Perfusion Solution, Vivacity Perfusion, SpecialtyCare, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the ?Cardiopulmonary Assisted Membrane Oxygenator Industry Forecast? looks at past sales and reviews total world Cardiopulmonary Assisted Membrane Oxygenator sales in 2025, providing a comprehensive analysis by region and market sector of projected Cardiopulmonary Assisted Membrane Oxygenator sales for 2026 through 2032. With Cardiopulmonary Assisted Membrane Oxygenator sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cardiopulmonary Assisted Membrane Oxygenator industry.

This Insight Report provides a comprehensive analysis of the global Cardiopulmonary Assisted Membrane Oxygenator landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cardiopulmonary Assisted Membrane Oxygenator portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Cardiopulmonary Assisted Membrane Oxygenator market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cardiopulmonary Assisted Membrane Oxygenator and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cardiopulmonary Assisted Membrane Oxygenator.

This report presents a comprehensive overview, market shares, and growth opportunities of Cardiopulmonary Assisted Membrane Oxygenator market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • VA (veno-arterial) ECMO
  • VV (veno-venous) ECMO
Segmentation by Application:
  • Hospital
  • Clinic
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • GETINGE
  • PROCIRCA
  • Perfusion Solution
  • Vivacity Perfusion
  • SpecialtyCare
  • Keystone Perfusion Services
  • Comprehensive Care Services
  • Memorial
Key Questions Addressed in this Report
What is the 10-year outlook for the global Cardiopulmonary Assisted Membrane Oxygenator market?
What factors are driving Cardiopulmonary Assisted Membrane Oxygenator market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cardiopulmonary Assisted Membrane Oxygenator market opportunities vary by end market size?
How does Cardiopulmonary Assisted Membrane Oxygenator break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Cardiopulmonary Assisted Membrane Oxygenator Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Cardiopulmonary Assisted Membrane Oxygenator by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Cardiopulmonary Assisted Membrane Oxygenator by Country/Region, 2021, 2025 & 2032
2.2 Cardiopulmonary Assisted Membrane Oxygenator Segment by Type
  2.2.1 VA (veno-arterial) ECMO
  2.2.2 VV (veno-venous) ECMO
  2.2.3 Cardiopulmonary Assisted Membrane Oxygenator Sales by Type
    2.2.3.1 Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Cardiopulmonary Assisted Membrane Oxygenator Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Cardiopulmonary Assisted Membrane Oxygenator Sale Price by Type (2021-2026)
2.3 Cardiopulmonary Assisted Membrane Oxygenator Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Others
  2.3.4 Cardiopulmonary Assisted Membrane Oxygenator Sales by Application
    2.3.4.1 Global Cardiopulmonary Assisted Membrane Oxygenator Sale Market Share by Application (2021-2026)
    2.3.4.2 Global Cardiopulmonary Assisted Membrane Oxygenator Revenue and Market Share by Application (2021-2026)
    2.3.4.3 Global Cardiopulmonary Assisted Membrane Oxygenator Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Cardiopulmonary Assisted Membrane Oxygenator Breakdown Data by Company
  3.1.1 Global Cardiopulmonary Assisted Membrane Oxygenator Annual Sales by Company (2021-2026)
  3.1.2 Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Company (2021-2026)
3.2 Global Cardiopulmonary Assisted Membrane Oxygenator Annual Revenue by Company (2021-2026)
  3.2.1 Global Cardiopulmonary Assisted Membrane Oxygenator Revenue by Company (2021-2026)
  3.2.2 Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Company (2021-2026)
3.3 Global Cardiopulmonary Assisted Membrane Oxygenator Sale Price by Company
3.4 Key Manufacturers Cardiopulmonary Assisted Membrane Oxygenator Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Cardiopulmonary Assisted Membrane Oxygenator Product Location Distribution
  3.4.2 Players Cardiopulmonary Assisted Membrane Oxygenator Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR CARDIOPULMONARY ASSISTED MEMBRANE OXYGENATOR BY GEOGRAPHIC REGION

4.1 World Historic Cardiopulmonary Assisted Membrane Oxygenator Market Size by Geographic Region (2021-2026)
  4.1.1 Global Cardiopulmonary Assisted Membrane Oxygenator Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Cardiopulmonary Assisted Membrane Oxygenator Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Cardiopulmonary Assisted Membrane Oxygenator Market Size by Country/Region (2021-2026)
  4.2.1 Global Cardiopulmonary Assisted Membrane Oxygenator Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Cardiopulmonary Assisted Membrane Oxygenator Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cardiopulmonary Assisted Membrane Oxygenator Sales Growth
4.4 APAC Cardiopulmonary Assisted Membrane Oxygenator Sales Growth
4.5 Europe Cardiopulmonary Assisted Membrane Oxygenator Sales Growth
4.6 Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Sales Growth

5 AMERICAS

5.1 Americas Cardiopulmonary Assisted Membrane Oxygenator Sales by Country
  5.1.1 Americas Cardiopulmonary Assisted Membrane Oxygenator Sales by Country (2021-2026)
  5.1.2 Americas Cardiopulmonary Assisted Membrane Oxygenator Revenue by Country (2021-2026)
5.2 Americas Cardiopulmonary Assisted Membrane Oxygenator Sales by Type (2021-2026)
5.3 Americas Cardiopulmonary Assisted Membrane Oxygenator Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Cardiopulmonary Assisted Membrane Oxygenator Sales by Region
  6.1.1 APAC Cardiopulmonary Assisted Membrane Oxygenator Sales by Region (2021-2026)
  6.1.2 APAC Cardiopulmonary Assisted Membrane Oxygenator Revenue by Region (2021-2026)
6.2 APAC Cardiopulmonary Assisted Membrane Oxygenator Sales by Type (2021-2026)
6.3 APAC Cardiopulmonary Assisted Membrane Oxygenator Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Cardiopulmonary Assisted Membrane Oxygenator by Country
  7.1.1 Europe Cardiopulmonary Assisted Membrane Oxygenator Sales by Country (2021-2026)
  7.1.2 Europe Cardiopulmonary Assisted Membrane Oxygenator Revenue by Country (2021-2026)
7.2 Europe Cardiopulmonary Assisted Membrane Oxygenator Sales by Type (2021-2026)
7.3 Europe Cardiopulmonary Assisted Membrane Oxygenator Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator by Country
  8.1.1 Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Revenue by Country (2021-2026)
8.2 Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Sales by Type (2021-2026)
8.3 Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cardiopulmonary Assisted Membrane Oxygenator
10.3 Manufacturing Process Analysis of Cardiopulmonary Assisted Membrane Oxygenator
10.4 Industry Chain Structure of Cardiopulmonary Assisted Membrane Oxygenator

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Cardiopulmonary Assisted Membrane Oxygenator Distributors
11.3 Cardiopulmonary Assisted Membrane Oxygenator Customer

12 WORLD FORECAST REVIEW FOR CARDIOPULMONARY ASSISTED MEMBRANE OXYGENATOR BY GEOGRAPHIC REGION

12.1 Global Cardiopulmonary Assisted Membrane Oxygenator Market Size Forecast by Region
  12.1.1 Global Cardiopulmonary Assisted Membrane Oxygenator Forecast by Region (2027-2032)
  12.1.2 Global Cardiopulmonary Assisted Membrane Oxygenator Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Cardiopulmonary Assisted Membrane Oxygenator Forecast by Type (2027-2032)
12.7 Global Cardiopulmonary Assisted Membrane Oxygenator Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 GETINGE
  13.1.1 GETINGE Company Information
  13.1.2 GETINGE Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
  13.1.3 GETINGE Cardiopulmonary Assisted Membrane Oxygenator Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 GETINGE Main Business Overview
  13.1.5 GETINGE Latest Developments
13.2 PROCIRCA
  13.2.1 PROCIRCA Company Information
  13.2.2 PROCIRCA Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
  13.2.3 PROCIRCA Cardiopulmonary Assisted Membrane Oxygenator Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 PROCIRCA Main Business Overview
  13.2.5 PROCIRCA Latest Developments
13.3 Perfusion Solution
  13.3.1 Perfusion Solution Company Information
  13.3.2 Perfusion Solution Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
  13.3.3 Perfusion Solution Cardiopulmonary Assisted Membrane Oxygenator Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Perfusion Solution Main Business Overview
  13.3.5 Perfusion Solution Latest Developments
13.4 Vivacity Perfusion
  13.4.1 Vivacity Perfusion Company Information
  13.4.2 Vivacity Perfusion Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
  13.4.3 Vivacity Perfusion Cardiopulmonary Assisted Membrane Oxygenator Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Vivacity Perfusion Main Business Overview
  13.4.5 Vivacity Perfusion Latest Developments
13.5 SpecialtyCare
  13.5.1 SpecialtyCare Company Information
  13.5.2 SpecialtyCare Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
  13.5.3 SpecialtyCare Cardiopulmonary Assisted Membrane Oxygenator Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 SpecialtyCare Main Business Overview
  13.5.5 SpecialtyCare Latest Developments
13.6 Keystone Perfusion Services
  13.6.1 Keystone Perfusion Services Company Information
  13.6.2 Keystone Perfusion Services Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
  13.6.3 Keystone Perfusion Services Cardiopulmonary Assisted Membrane Oxygenator Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Keystone Perfusion Services Main Business Overview
  13.6.5 Keystone Perfusion Services Latest Developments
13.7 Comprehensive Care Services
  13.7.1 Comprehensive Care Services Company Information
  13.7.2 Comprehensive Care Services Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
  13.7.3 Comprehensive Care Services Cardiopulmonary Assisted Membrane Oxygenator Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Comprehensive Care Services Main Business Overview
  13.7.5 Comprehensive Care Services Latest Developments
13.8 Memorial
  13.8.1 Memorial Company Information
  13.8.2 Memorial Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
  13.8.3 Memorial Cardiopulmonary Assisted Membrane Oxygenator Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Memorial Main Business Overview
  13.8.5 Memorial Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION



LIST OF TABLES

Table 1. Cardiopulmonary Assisted Membrane Oxygenator Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Cardiopulmonary Assisted Membrane Oxygenator Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of VA (veno-arterial) ECMO
Table 4. Major Players of VV (veno-venous) ECMO
Table 5. Global Cardiopulmonary Assisted Membrane Oxygenator Sales by Type (2021-2026) & (Units)
Table 6. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Type (2021-2026)
Table 7. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue by Type (2021-2026) & ($ million)
Table 8. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Type (2021-2026)
Table 9. Global Cardiopulmonary Assisted Membrane Oxygenator Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Cardiopulmonary Assisted Membrane Oxygenator Sale by Application (2021-2026) & (Units)
Table 11. Global Cardiopulmonary Assisted Membrane Oxygenator Sale Market Share by Application (2021-2026)
Table 12. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue by Application (2021-2026) & ($ million)
Table 13. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Application (2021-2026)
Table 14. Global Cardiopulmonary Assisted Membrane Oxygenator Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Cardiopulmonary Assisted Membrane Oxygenator Sales by Company (2021-2026) & (Units)
Table 16. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Company (2021-2026)
Table 17. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Company (2021-2026)
Table 19. Global Cardiopulmonary Assisted Membrane Oxygenator Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Cardiopulmonary Assisted Membrane Oxygenator Producing Area Distribution and Sales Area
Table 21. Players Cardiopulmonary Assisted Membrane Oxygenator Products Offered
Table 22. Cardiopulmonary Assisted Membrane Oxygenator Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Cardiopulmonary Assisted Membrane Oxygenator Sales by Geographic Region (2021-2026) & (Units)
Table 26. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share Geographic Region (2021-2026)
Table 27. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Cardiopulmonary Assisted Membrane Oxygenator Sales by Country/Region (2021-2026) & (Units)
Table 30. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Country/Region (2021-2026)
Table 31. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Cardiopulmonary Assisted Membrane Oxygenator Sales by Country (2021-2026) & (Units)
Table 34. Americas Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Country (2021-2026)
Table 35. Americas Cardiopulmonary Assisted Membrane Oxygenator Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Cardiopulmonary Assisted Membrane Oxygenator Sales by Type (2021-2026) & (Units)
Table 37. Americas Cardiopulmonary Assisted Membrane Oxygenator Sales by Application (2021-2026) & (Units)
Table 38. APAC Cardiopulmonary Assisted Membrane Oxygenator Sales by Region (2021-2026) & (Units)
Table 39. APAC Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Region (2021-2026)
Table 40. APAC Cardiopulmonary Assisted Membrane Oxygenator Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Cardiopulmonary Assisted Membrane Oxygenator Sales by Type (2021-2026) & (Units)
Table 42. APAC Cardiopulmonary Assisted Membrane Oxygenator Sales by Application (2021-2026) & (Units)
Table 43. Europe Cardiopulmonary Assisted Membrane Oxygenator Sales by Country (2021-2026) & (Units)
Table 44. Europe Cardiopulmonary Assisted Membrane Oxygenator Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Cardiopulmonary Assisted Membrane Oxygenator Sales by Type (2021-2026) & (Units)
Table 46. Europe Cardiopulmonary Assisted Membrane Oxygenator Sales by Application (2021-2026) & (Units)
Table 47. Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Sales by Country (2021-2026) & (Units)
Table 48. Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Sales by Type (2021-2026) & (Units)
Table 50. Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Sales by Application (2021-2026) & (Units)
Table 51. Key Market Drivers & Growth Opportunities of Cardiopulmonary Assisted Membrane Oxygenator
Table 52. Key Market Challenges & Risks of Cardiopulmonary Assisted Membrane Oxygenator
Table 53. Key Industry Trends of Cardiopulmonary Assisted Membrane Oxygenator
Table 54. Cardiopulmonary Assisted Membrane Oxygenator Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Cardiopulmonary Assisted Membrane Oxygenator Distributors List
Table 57. Cardiopulmonary Assisted Membrane Oxygenator Customer List
Table 58. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Forecast by Region (2027-2032) & (Units)
Table 59. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Cardiopulmonary Assisted Membrane Oxygenator Sales Forecast by Country (2027-2032) & (Units)
Table 61. Americas Cardiopulmonary Assisted Membrane Oxygenator Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Cardiopulmonary Assisted Membrane Oxygenator Sales Forecast by Region (2027-2032) & (Units)
Table 63. APAC Cardiopulmonary Assisted Membrane Oxygenator Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Cardiopulmonary Assisted Membrane Oxygenator Sales Forecast by Country (2027-2032) & (Units)
Table 65. Europe Cardiopulmonary Assisted Membrane Oxygenator Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Sales Forecast by Country (2027-2032) & (Units)
Table 67. Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Forecast by Type (2027-2032) & (Units)
Table 69. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Forecast by Application (2027-2032) & (Units)
Table 71. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. GETINGE Basic Information, Cardiopulmonary Assisted Membrane Oxygenator Manufacturing Base, Sales Area and Its Competitors
Table 73. GETINGE Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
Table 74. GETINGE Cardiopulmonary Assisted Membrane Oxygenator Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. GETINGE Main Business
Table 76. GETINGE Latest Developments
Table 77. PROCIRCA Basic Information, Cardiopulmonary Assisted Membrane Oxygenator Manufacturing Base, Sales Area and Its Competitors
Table 78. PROCIRCA Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
Table 79. PROCIRCA Cardiopulmonary Assisted Membrane Oxygenator Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. PROCIRCA Main Business
Table 81. PROCIRCA Latest Developments
Table 82. Perfusion Solution Basic Information, Cardiopulmonary Assisted Membrane Oxygenator Manufacturing Base, Sales Area and Its Competitors
Table 83. Perfusion Solution Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
Table 84. Perfusion Solution Cardiopulmonary Assisted Membrane Oxygenator Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Perfusion Solution Main Business
Table 86. Perfusion Solution Latest Developments
Table 87. Vivacity Perfusion Basic Information, Cardiopulmonary Assisted Membrane Oxygenator Manufacturing Base, Sales Area and Its Competitors
Table 88. Vivacity Perfusion Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
Table 89. Vivacity Perfusion Cardiopulmonary Assisted Membrane Oxygenator Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Vivacity Perfusion Main Business
Table 91. Vivacity Perfusion Latest Developments
Table 92. SpecialtyCare Basic Information, Cardiopulmonary Assisted Membrane Oxygenator Manufacturing Base, Sales Area and Its Competitors
Table 93. SpecialtyCare Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
Table 94. SpecialtyCare Cardiopulmonary Assisted Membrane Oxygenator Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. SpecialtyCare Main Business
Table 96. SpecialtyCare Latest Developments
Table 97. Keystone Perfusion Services Basic Information, Cardiopulmonary Assisted Membrane Oxygenator Manufacturing Base, Sales Area and Its Competitors
Table 98. Keystone Perfusion Services Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
Table 99. Keystone Perfusion Services Cardiopulmonary Assisted Membrane Oxygenator Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Keystone Perfusion Services Main Business
Table 101. Keystone Perfusion Services Latest Developments
Table 102. Comprehensive Care Services Basic Information, Cardiopulmonary Assisted Membrane Oxygenator Manufacturing Base, Sales Area and Its Competitors
Table 103. Comprehensive Care Services Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
Table 104. Comprehensive Care Services Cardiopulmonary Assisted Membrane Oxygenator Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Comprehensive Care Services Main Business
Table 106. Comprehensive Care Services Latest Developments
Table 107. Memorial Basic Information, Cardiopulmonary Assisted Membrane Oxygenator Manufacturing Base, Sales Area and Its Competitors
Table 108. Memorial Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
Table 109. Memorial Cardiopulmonary Assisted Membrane Oxygenator Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Memorial Main Business
Table 111. Memorial Latest Developments

LIST OF FIGURES

Figure 1. Picture of Cardiopulmonary Assisted Membrane Oxygenator
Figure 2. Cardiopulmonary Assisted Membrane Oxygenator Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Cardiopulmonary Assisted Membrane Oxygenator Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Country/Region (2025)
Figure 10. Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of VA (veno-arterial) ECMO
Figure 12. Product Picture of VV (veno-venous) ECMO
Figure 13. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Type in 2026
Figure 14. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Type (2021-2026)
Figure 15. Cardiopulmonary Assisted Membrane Oxygenator Consumed in Hospital
Figure 16. Global Cardiopulmonary Assisted Membrane Oxygenator Market: Hospital (2021-2026) & (Units)
Figure 17. Cardiopulmonary Assisted Membrane Oxygenator Consumed in Clinic
Figure 18. Global Cardiopulmonary Assisted Membrane Oxygenator Market: Clinic (2021-2026) & (Units)
Figure 19. Cardiopulmonary Assisted Membrane Oxygenator Consumed in Others
Figure 20. Global Cardiopulmonary Assisted Membrane Oxygenator Market: Others (2021-2026) & (Units)
Figure 21. Global Cardiopulmonary Assisted Membrane Oxygenator Sale Market Share by Application (2025)
Figure 22. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Application in 2026
Figure 23. Cardiopulmonary Assisted Membrane Oxygenator Sales by Company in 2026 (Units)
Figure 24. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Company in 2026
Figure 25. Cardiopulmonary Assisted Membrane Oxygenator Revenue by Company in 2026 ($ millions)
Figure 26. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Company in 2026
Figure 27. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Cardiopulmonary Assisted Membrane Oxygenator Sales 2021-2026 (Units)
Figure 30. Americas Cardiopulmonary Assisted Membrane Oxygenator Revenue 2021-2026 ($ millions)
Figure 31. APAC Cardiopulmonary Assisted Membrane Oxygenator Sales 2021-2026 (Units)
Figure 32. APAC Cardiopulmonary Assisted Membrane Oxygenator Revenue 2021-2026 ($ millions)
Figure 33. Europe Cardiopulmonary Assisted Membrane Oxygenator Sales 2021-2026 (Units)
Figure 34. Europe Cardiopulmonary Assisted Membrane Oxygenator Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Sales 2021-2026 (Units)
Figure 36. Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Revenue 2021-2026 ($ millions)
Figure 37. Americas Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Country in 2026
Figure 38. Americas Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Country (2021-2026)
Figure 39. Americas Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Type (2021-2026)
Figure 40. Americas Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Application (2021-2026)
Figure 41. United States Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Region in 2026
Figure 46. APAC Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Region (2021-2026)
Figure 47. APAC Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Type (2021-2026)
Figure 48. APAC Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Application (2021-2026)
Figure 49. China Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2021-2026 ($ millions)
Figure 53. India Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Country in 2026
Figure 57. Europe Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Country (2021-2026)
Figure 58. Europe Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Type (2021-2026)
Figure 59. Europe Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Application (2021-2026)
Figure 60. Germany Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2021-2026 ($ millions)
Figure 61. France Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Application (2021-2026)
Figure 68. Egypt Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Cardiopulmonary Assisted Membrane Oxygenator in 2026
Figure 74. Manufacturing Process Analysis of Cardiopulmonary Assisted Membrane Oxygenator
Figure 75. Industry Chain Structure of Cardiopulmonary Assisted Membrane Oxygenator
Figure 76. Channels of Distribution
Figure 77. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Forecast by Region (2027-2032)
Figure 78. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share Forecast by Application (2027-2032)


More Publications